Esperion Therapeutics
ESPR
ESPR
40 hedge funds and large institutions have $51.9M invested in Esperion Therapeutics in 2014 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
40
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.69M | |
| 2 | +$1.88M | |
| 3 | +$886K | |
| 4 |
Bank of New York Mellon
New York
|
+$586K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$378K |
Top Sellers
| 1 | -$3.54M | |
| 2 | -$1.02M | |
| 3 | -$752K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$455K |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$454K |